View of CONSTRUCT THE MODEL OF COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB VERSUS STANDARD THERAPY IN THE TREATMENT OF NON- SMALL CELL LUNG CANCER IN VIETNAM

Return to Article Details CONSTRUCT THE MODEL OF COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB VERSUS STANDARD THERAPY IN THE TREATMENT OF NON- SMALL CELL LUNG CANCER IN VIETNAM Download Download PDF